1SIMONNEAU G,GALIE N,RUBIN L J,et al.Clinical classification of pulmonary hypertension[J].J Am Coll Cardiol,2004,43 (12 Suppl S):5S-12S. 被引量：1
2THOMSON J R,MACHADO R D,PAUCIULO M W,et al.Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-Ⅱ,a receptor member of the TGF-beta family[J].J Med Genet,2000,37 (10):741-745. 被引量：1
3RINDERMANN M,GRUNIG E,VON HIPPEL A,et al.Primary pulmonary hypertension may be a heterogeneous disease with a second locus on chromosome 2q31[J].J Am Coll Cardiol,2003,41 (12):2237-2244. 被引量：1
4HUMBERT M,DENG Z,SIMONNEAU G,et al.BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives[J].Eur Respir J,2002,20 (3):518-523. 被引量：1
5RUNO J R,VNENCAK-JONES C L,PRINCE M,et al.Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor Ⅱ[J].Am J Respir Crit Care Med,2003,167 (6):889-894. 被引量：1
6PIETRA G G,CAPRON F,STEWART S,et al.Pathologic assessment of vasculopathies in pulmonary hypertension[J].J Am Coll Cardiol,2004,43 (12 Suppl S):25S-32S. 被引量：1
3IVY D D,KINSELLA J P,ZIEGLER J W,et al.Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease [ J ].J Thorac Cardiovasc Surg,1998,115 (4):875-882. 被引量：1
4RIMENSBERGER P C,SPAHR-SCHOPFER I,BERNER M,et al.Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease:vasodilator capacity and cellular mechanisms [ J ].Circulation,2001,103 (4):544-548. 被引量：1
5CHRISTENSON J,LAVOIE A,O'CONNOR M,et al.The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide [ J].Am J Respir Crit Care Med,2000,161 (5):1443-1449. 被引量：1
6WEDGWOOD S,MCMULLAN D M,BEKKER J M,et al.Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy [J].Circ Res,2001,89 (4):357-364. 被引量：1
7KAGEYAMA K,SHIME N,HIROSE M,et al.Factors contributing to successful discontinuation from inhaled nitric oxide therapy in pediatric patients after congenital cardiac surgery [ J ].Pediatr Crit Care Med,2004,5 (4):351-355. 被引量：1
